Shares of Aptose Biosciences Inc. (TSE:APS - Get Free Report) NASDAQ: APTO crossed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of C$2.06 and traded as low as C$2.01. Aptose Biosciences shares last traded at C$2.30, with a volume of 10,425 shares.
Aptose Biosciences Stock Performance
The company has a debt-to-equity ratio of -117.37, a current ratio of 1.05 and a quick ratio of 5.41. The company has a 50 day simple moving average of C$2.05 and a 200-day simple moving average of C$4.71. The stock has a market cap of C$96.45 million, a P/E ratio of -0.45 and a beta of 1.36.
Aptose Biosciences Company Profile
(
Get Free Report)
Aptose Biosciences Inc, a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies.
Recommended Stories
Before you consider Aptose Biosciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aptose Biosciences wasn't on the list.
While Aptose Biosciences currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
